|
⚲
|
| Calistoga Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001385313 |
| Sale | 2009-05-01 ($31.0 M Offered, $15.0 M Sold) |
| Fund | |
| Phone | 2067284700 |
| Address | 2101 Fourth Avenue Seattle, 98121 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Robert Douglas | |
| James Topper | |
| Ed Hurwitz | |
| W Michael Gallatin | |
| Richard Lin | |
| Aaron Coe | |
| Carol Gallagher |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Norgard Capital II, LP - A4
✚
|
0.0 | |
|
Himle Karen L
✚
|
0.0 | |
|
No Brick LLC
✚
|
0.0 | |
|
No-H2O USA Inc
✚
|
0.0 | |
|
Noble USA Home & Auto LLC
✚
|
0.0 | |
|
Fitscript LLC
✚
|
0.0 | |
|
Norberg James
✚
|
0.0 | |
|
Norden Crown Metals Corp
✚
|
0.0 | |
|
Norf 4 Opportunity Zone Fund LLC
✚
|
0.0 | |
|
Watler D Hughes
✚
|
0.0 |